Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Squires, H. orcid.org/0000-0002-2776-4014, Stevenson, M. orcid.org/0000-0002-3099-9877, Simpson, E. orcid.org/0000-0001-7353-5979 et al. (2 more authors) (2016) Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 34 (7). pp. 673-680. ISSN 1170-7690

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 Springer International Publishing Switzerland. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy. The final publication is available at Springer via http://dx.doi.org/10.1007/s40273-016-0386-z
Dates:
  • Published: July 2016
  • Published (online): 18 February 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 16 May 2017 11:06
Last Modified: 02 Jul 2017 04:38
Published Version: https://doi.org/10.1007/s40273-016-0386-z
Status: Published
Publisher: Springer Verlag
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-016-0386-z
Related URLs:

Share / Export

Statistics